PREVALENCE OF RASADHATU DUSHTI IN PARTICIPANTS AT RISK OF CARDIOVASCULAR DISEASE AND COMPARATIVE EFFECT OF PANCHKOL CHURNA AGAINST LIFE-STYLE MODIFICATION AS A RISK REDUCTION MEASURE: AN OBSERVATIONAL AND EXPLORATORY CLINICAL STUDY

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•Stage :1 Inclusion Criteria:
•1.Subjects of either gender in the age group of 30-60 years (both years inclusive).
•2.Subjects fulfilling any one of the following criteria for abnormal lipid profile:
•a)Subjects with Total cholesterol level ( >200mg/dl).
•b)Subjects with Triglyceride level ( >150mg/dl).
•c)Subjects with HDL level ( < 40mg/dl).
•d)Subjects with LDL level ( >140mg/dl).
•3.Subjects willing to participate and provide informed written consent
•4.Participants fulfilling any three of the following criteria will be selected to participate in the survey:
•i.Overweight/Class-1 obese (body mass index [BMI]: 25â??35 kg/m2), Subjects with low BMI but abnormal lipid profile, or subjects with both or at least any of the above diagnostic criteria will be selected for the study.
•ii.Subjects having a family history of cardiovascular events like myocardial infarction, stroke, or peripheral vascular occlusive diseases.
•iii.Subjects with history of tobacco smoking.
•iv.Subjects with documented history of hypertension.
•v.Subjects with documented history of diabetes mellitus.
•5.Subjects with RAS-RCVD Score >=10.
•6.Subject willing to participate and ready to give informed consent.
•1.Subjects at risk of CVDs diagnosed from observational study.
•2.Subjects with RAS-RCVD Score >=10.
•3.Subject willing to participate and ready to give informed consent.

•Stage 1: Exclusion Criteria:
•1.Subjects having history of cardiovascular events like myocardial infarction, stroke, or peripheral vascular occlusive diseases.
•2.Subjects with documented history of hypertension.
•3.Subjects with documented history of diabetes mellitus.
•4.Patient with history of clinically-active hepatic or peptic ulcer disease.
•5.Subjects planning to undergo surgery in next 3 months will be excluded from the study.
•6.Subjects who are pregnant, breast feeding or planning to become pregnant during the study.
•7.Subjects participated in any other clinical trials within thirty (30) days prior to screening.
•8.Patient with history of severe allergy or anaphylactic reaction.
•9.Any other condition which the investigator think may jeopardize the participant condition.
•Stage 2: Exclusion Criteria:
•1.Subjects having history of cardiovascular events like myocardial infarction, stroke, or peripheral vascular occlusive diseases.
•2.Subjects with documented history of hypertension.
•3.Subjects with documented history of diabetes mellitus.
•4.Patient with history of clinically-active hepatic or peptic ulcer disease.
•5.Subjects planning to undergo surgery in next 3 months will be excluded from the study.

发起方